NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Stock Information | RedChip

NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Listen to this Section


$1.75
+0.0100 ( +0.58% ) 62.5K

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Market Data


Open


$1.75

Previous close


$1.74

Volume


62.5K

Market cap


$18.51M

Day range


$1.74 - $1.95

52 week range


$1.73 - $7.33

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 19 Apr 30, 2024
10-k/a Quarterly Reports 17 Apr 29, 2024
8-k 8K-related 21 Apr 19, 2024
8-k 8K-related 16 Apr 15, 2024
8-k 8K-related 16 Apr 02, 2024
10-k Annual reports 98 Mar 29, 2024
8-k 8K-related 16 Mar 28, 2024
8-k 8K-related 15 Mar 21, 2024
def Proxies and info statements 4 Mar 11, 2024
8-k 8K-related 18 Mar 06, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.